Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017102
The University of Chicago
Search grants from The University of Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Engineering Injectable Microporous Hydrogels for Brain Repair
Addressing Global TB Prevention and Control in All Populations and Strengthening
Developmental Nephrology
Individual Differences and Moderators of Adjustment
Assembly and Activation of Enzyme-Ssdna Complexes
Recently added grants:
Referral Ctr-Animal models of human genetic disease
Regulation of alveolar epithelial regeneration by T cells
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
Administrative and Faculty Development Core
Transgenic Animal Genotyping and Phenotyping Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017102-013
Application #
7191420
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
The University of Chicago
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
Comments
Be the first to comment on this grant